Company profile:

Lionco Pharmaceutical Group Co., Ltd.

Country: China
Legal Representative: Tao Lingping
Business status: Active
Industry: Other general retail
Company type: Other joint stock limited companies (listed)
Founding date: 2003-12-24
Approval date: 2023-06-09
Chinese company name: 灵康*业集团股份有限公司
Telephone: 0893-78308** ,0571-81103508180769378** ,0571-811035**
Email: **aobinlove34@126.com , **2639837@qq.com , **621@163.com , **@lingkang.com.cn ,

Lionco Pharmaceutical Group Co., Ltd.

Employees 0-100 Detail ( 72.48% of companies have fewer than 5 employees. )
Registered capital 721,220,000 RMB Detail ( 6.3% of companies have registered capital less than 500,000. )
Paid up capital Over 100 Million RMB Detail ( 42.7% of companies have paid up capital less than 500,000. )
The preceding data analysis is derived from a sample of 2 million Chinese companies with import and export licenses, as of October 9, 2023.

Company's Shareholders

other shareholders
China Resources Yuanta Fund-Zhu Mingliang-China Resources Yuanta Fund Chuangying No. 1 Single Asset Management Plan
Shan Yinghao
Jiang Xiaodong
Lingkang Holding Group Co., Ltd.
Special securities account for repurchase of Lingkang Pharmaceutical Group Co., Ltd.
Wang Wennan
Golden Eagle Fund-Shen Jianjun-Golden Eagle Preferred No. 36 Single Asset Management Plan
Tao Xiaogang
Tao Linggang
Tao Lingping

Company's business scope

licensed items:Drug Wholesalepharmaceutical productionPharmaceutical commissioned productionDrug retailDrug internet information service(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the permits of relevant departments)General project:Technical Servicestechnology developmenttechnical consultingTechnology Exchangetechnology transferTechnology Promotionhousing leaseNon-residential real estate leasesfood salesOnly sell prepackaged food);Healthy foodprepackagedSale(Except for projects subject to approval by law,Independent development is not prohibited by laws and regulations、restricted business activities)

Report on this company:

Supplier Verification
$29
  • Company General Information
  • Company Registration Details
  • Shareholder Information
  • Main Personnels
  • Import & Export Credit
  • Legal Records Table
  • Government Records Table
Full Background Check
$99
  • Company General Information
  • Company Registration Details
  • Shareholder Information
  • Main Personnels
  • Import & Export Credit
  • Legal Records Table
  • Government Records Table
  • Company Change Record
  • Company Legal Inspection
  • Ongoing Judicial Case
  • Case Filings History
  • Administrative Penalties
  • Related Companies Risks
Pre-litigation Investigation
$199
  • Company General Information
  • Company Registration Details
  • Shareholder Information
  • Main Personnels
  • Import & Export Credit
  • Legal Records Table
  • Government Records Table
  • Company Change Record
  • Company Legal Inspection
  • Ongoing Judicial Case
  • Case Filings History
  • Administrative Penalties
  • Related Companies Risks
  • Branches & Subsidiaries
  • Advanced Registration Information
  • Legal Representative Information
  • Suspected Actual Controller
  • Company Investment
  • Company Annual Report
  • Company Intellectual Property

location of Lionco Pharmaceutical Group Co., Ltd.

Address No. 20, National Highway 349 (Jieba Township Section), Nedong District, Shannan City, Tibet Autonomous Region
Province Tibet China Tibet
City Shannan

Ranking of Shannan Among Chinese Cities

Area of Industrial, Manufacturing of the city(Shannan )

Area: 0.40 km²
Chinese city rankings: 304

Population of the city(Shannan )

Population: 90,000
Chinese city rankings: 307

Companies in the city(Shannan)

Companies: 22
Chinese city rankings: 351

Area of Logistics and Warehouse of the city(Shannan )

Area: 0.32 km²
Chinese city rankings: 284

Frequently Asked Questions

1.Company information

Email:**@lingkang.com.cn

Phone number:0893-78308**

The company was started in 2003-12-24